EFFECT OF OBESITY ON THE TIME REQUIRED ACHIEVING A FEO2 OF 90% DURING PREOXYGENATION
Journal: Journal of Dibetes and Obesity (Vol.2, No. 4)Publication Date: 2015-12-22
Authors : Paul F. White;
Page : 1-6
Keywords : Obesity; BMI; Pre oxygenation; End-tidal expiratory oxygen; Oxygen desaturation;
Abstract
An end-expiratory oxygen (FEO2) concentration > 90% is desirable prior to tracheal intubation. We hypothesized that the time required for pre oxygenation to achieve an FEO2 of 90% was related to patient Body Mass Index (BMI). Seventy- seven consenting patients undergoing a rapid sequence induction were enrolled. After the anesthesia rebreathing circuit was filled with 100% oxygen for 4 min, these unpremeditated patients were instructed to breathe normally following application of a tight-fitting face mask with oxygen flowing at 10 L min-1. End-tidal oxygen and carbon dioxide values were recorded during the pre oxygenation period. Induction of anesthesia was performed when the FEO2 reached 90% or after 5 min of pre oxygenation in a standardized fashion. The times to achieve an FEO2 of 90% were 152 ± 57, 136 ± 62 and 136 ± 70 sec in the normal, overweight and obese subgroups, respectively. A total of 7 patients failed to achieve an FEO2 90% after 5 min of preoxygenation. Four patients also experienced a decrease in SpO2 < 95% during the apneic period prior to tracheal intubation (3 in the obese group and 1 in the overweight group). The mean BMI (± SD) of the patients who failed to achieve a FEO2 of 90% was 40 ± 9 kg/m?. The time required to achieve an FEO2 of 90% during preoxygenation period was unrelated to the patient's BMI. However, morbidly obese patients were more likely to experience a fall in their SpO2 to < 95% during the induction period.
Other Latest Articles
- THE HIGH PREVALENCE OF OVERWEIGHT AND OBESITY IN PATIENTS WITH DIABETES MELLITUS IN YAZD
- DETERMINANTS OF MISPERCEPTION OF WEIGHT STATUS AMONG A COMMUNITY OF ADULTS IN THE REGION OF SOUSSE, TUNISIA
- COMPOSITION DIVERSITY AND ABUNDANCE OF GUT MICROBIOME IN PREDIABETES AND TYPE 2 DIABETES
- COMPARATIVE EFFICIENCY OF SULFONYLUREA AND/OR DIPEPTIDYL PEPTIDASE-4 INHIBITOR IN BASAL-SUPPORTED ORAL THERAPY IN JAPANESE PATIENTS WITH TYPE 2 DIABETES (JDDM39)
- INTEGRATION OF OMICS DATA FOR OBESITY
Last modified: 2017-01-10 16:33:28